HHS Influencers' focus on "Big Food" and "Big Pharma" (X data)

Current month
Previous month
*New HHS Influencer
**Returning HHS Influencer

Notable new X followings

CMS Administrator Mehmet Oz

  • FII Institute:
    Saudi government-backed nonprofit; Administrator Oz spoke at its 2026 summit in Miami

NIH Director Jay Bhattacharya

  • Anil Shanker:
    Genomics researcher; Meharry Medical College SVP for Research and Innovation; Vanderbilt University adjunct faculty member
  • David Sinclair:
    Biotech entrepreneur and Harvard genetics professor; argued "aging could soon be reversible"
  • Paul Thompson:
    USC neurology/psychiatry professor; leads ENIGMA, a global consortium analyzing 31,000+ brain scans
  • Joseph Younis:
    Neuroscientist; founder of OpenPeers, an "LLM for medical research"

HHS Senior Advisor Calley Means

  • Michael Boes:
    Steak 'n Shake's new Chief MAHA Officer; previously an HHS senior advisor until April 2026
  • Matthew Buckley:
    Founder of the No Fallen Heroes Foundation, which promotes "psychedelic-assisted therapy"
  • Ford Smith:
    Investor in food/beverage, health tech, psychedelics, biopharma, cannabis, and regenerative agriculture companies

New Trump Administration hires and nominees

HireBackgroundPharma PerspectivesFood Perspectives
Jonathan M. Green,
CEO of NIH Clinical Center

Previously Director of NIH’s Office of Human Subjects Research Protections (2018–2026); former professor of medicine, pathology, and immunology at Washington University in St. Louis[1]

Coauthored a report on consolidation among for-profit institutional review boards (IRBs) that examined declining federal oversight and client-driven conflicts of interest and advocated that IRBs be “not-for-profit” and “funded by the government”[2]

N/A

Casey B. Mulligan,
Chief Economist and Chief Regulatory Officer, HHS

Previously Chief Counsel for Advocacy at the Small Business Administration (2025–2026) and Chief Economist at the Council of Economic Advisors (2018–2019); economics professor at the University of Chicago[3]

Argued in a 2021 paper that “FDA approval barriers limit competition”; described Washington’s “swarms of drug-company lobbyists” and wrote that “market forces and patient-driven care will restrain drug prices” in a 2022 op-ed[4]

N/A

Nicole Saphier,
Nominee for U.S. Surgeon General

Radiologist and Director of Breast Imaging at Memorial Sloan Kettering Monmouth, former Fox News medical contributor, and author of the 2020 book Make America Healthy Again: How Bad Behavior and Big Government Caused a Trillion-Dollar Crisis[5]

Stated in November 2024 on “Fox & Friends” that GLP-1 drugs are “widely overutilized,” citing cost and potential side effects; more recently, acknowledged their “clear” benefits backed by “robust evidence” but emphasized prioritizing “the basics”[6]

Encouraged listeners on her podcast that “you don’t need to go fully vegetarian or vegan,” but to “shift your plate just a little bit” – adding fruits and leafy greens and “maybe” going plant-based one day a week[7]

Erica Schwartz,
Nominee for CDC Director

Deputy Surgeon General during the first Trump Administration with an extensive career in the U.S. Navy, U.S. Coast Guard, and the Commissioned Corps of the U.S. Public Health Service[8]

Studied how vaccinated U.S. military recruits responded to the flu vaccine in 2011 and found that they showed a weaker-than-expected immune response to the circulating H1N1 strain, likely because the virus had changed slightly from the strain used in the vaccine[9]

N/A

Health care op-eds published in The New York Times, The Wall Street Journal, and The Washington Post


SECTION 2

THE COMMERCIAL THEATER

Lobbying registrations by health care organizations

128health care company registrations this month
|
807total lobbying registrations filed this month
|
3companies hired multiple lobbying firms
🔍
CompanyLobbying FirmDate
ALLIED OMSFARRAGUT PARTNERS LLP04/01/2026
EMPOWER CLINIC SERVICES, LLC DBD EMPOWER PHARMACYCORNERSTONE GOVERNMENT AFFAIRS, INC.04/01/2026
HCBS ADVOCACY, LLCKEAST STRATEGIC SOLUTIONS, LLC04/01/2026
MAIN LINE HEALTHAXADVOCACY GOVERNMENT RELATIONS04/01/2026
N BRERETON MEDICAL TECHNOLOGIESERVIN GRAVES STRATEGY GROUP, LLC04/01/2026
TALKIATRY MANAGEMENT SERVICESLIBERTY PARTNERS GROUP, LLC04/02/2026
PH HEALTHCARE INVESTORS, LLCTIMOTHY R. RUPLI & ASSOCIATES, INC.04/02/2026
SKINCURE ONCOLOGYLIBERTY PARTNERS GROUP, LLC04/02/2026
VALTHOS INC.INVARIANT LLC04/02/2026
ATARA BIOTHERAPEUTICS, INC.JEFFREY J. KIMBELL & ASSOCIATES, INC.04/03/2026
ECU HEALTHHALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.04/03/2026
HEMOPHILIA FEDERATION OF AMERICASIDLEY AUSTIN LLP04/03/2026
INDEMEDJEFFREY J. KIMBELL & ASSOCIATES, INC.04/03/2026
INSURANCE WATCHDOG COALITIONSCARLET SOLUTIONS, LLC04/03/2026
KYVERNA THERAPEUTICS, INC.BROWNSTEIN HYATT FARBER SCHRECK, LLP04/03/2026
MAGNOLIA MEDICAL TECHNOLOGIES, INC.JEFFREY J. KIMBELL & ASSOCIATES, INC.04/03/2026
MAGNUS MEDICAL, INC.JEFFREY J. KIMBELL & ASSOCIATES, INC.04/03/2026
PRECISION MOTION HEALTHCROSSROADS STRATEGIES, LLC04/03/2026
SPINAL STABILIZATION TECHNOLOGIES, LTDWINNING STRATEGIES WASHINGTON04/03/2026
IATION FOR CANCER RESEARCHIKON PUBLIC AFFAIRS04/04/2026
AMERICAN COUNCIL OF ACADEMIC PHYSICAL THERAPYLOBBYIT.COM04/06/2026
PHILLY PHARMACIESMR. H.R. BERT PENA04/06/2026
ALPHA-1 FOUNDATIONHEALTH AND MEDICINE COUNSEL, LLC04/07/2026
AMERICAN ACADEMY OF NEUROLOGYFAEGRE DRINKER BIDDLE & REATH LLP04/07/2026
AMERICAN ALLIANCE OF ORTHOPAEDIC EXECUTIVESHOOPER, LUNDY & BOOKMAN, P.C.04/07/2026
BLUEPRINT BIOSECURITY ACTIONCORNERSTONE GOVERNMENT AFFAIRS, INC.04/07/2026
CABANA MENTAL HEALTHTHE DIONNE COMPANY04/07/2026
COALITION FOR HEMOPHILIA BHEALTH AND MEDICINE COUNSEL, LLC04/07/2026
CURIE BIO OPERATIONS, LLCALSTON & BIRD LLP04/07/2026
DYNE THERAPEUTICS, INC.W STRATEGIES, LLC04/07/2026
GAUCHER COMMUNITY ALLIANCEHEALTH AND MEDICINE COUNSEL, LLC04/07/2026
KAHUKU MEDICAL CENTERTHE WAYFINDER GROUP04/07/2026
NOVO NORDISK, INC.S-3 GROUP04/07/2026
SINAI HEALTH SYSTEMBARNES & THORNBURG, LLP04/07/2026
THE CURE COALITIONTHE BERNHARDT GROUP LLC04/07/2026
THE REE WYNN FOUNDATIONHEALTH AND MEDICINE COUNSEL, LLC04/07/2026
VOICES AGAINST BRAIN CANCERHEALTH AND MEDICINE COUNSEL, LLC04/07/2026
ABRIDGE AI INC.INVARIANT LLC04/08/2026
CONVERGE MEDICAL TECHNOLOGYPROSPERING SOLUTIONS, LLC FKA JOHN C. SNYDER III04/08/2026
ENNOBLE CARE, LLCRUBIN HEALTH POLICY CONSULTING, LLC04/08/2026
THE AMERICAN COLLEGE OF LIFESTYLE MEDICINE (ACLM)VENN STRATEGIES04/08/2026
TRULIEVEPITTMAN LAW GROUP04/08/2026
BENEFIS HOSPITALSLNE GROUP04/09/2026
CLEVELAND CLINICADAPTIVE GOVERNMENT RELATIONS04/09/2026
FROEDTERT BLUEMOUND REHABILITATION HOSPITALLNE GROUP04/09/2026
SAFE ALLIANCEADVANCED ENERGY ADVISORS04/09/2026
THE ARC OF LOUDONLNE GROUP04/09/2026
UNITED STATES OF CARE CAMPAIGNSPLITOAK STRATEGIES LLC04/09/2026
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINESNATALIE FRAMSTED D/B/A NATALIE FRAMSTED04/10/2026
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINESTYLER ROTUNDO D/B/A TYLER ROTUNDO04/10/2026
ALABAMA SCHOOL OF HEALTHCARE SCIENCES FOUNDATIONPEARSON34 CONSULTING04/10/2026
DELCATH SYSTEMS, INC.BGR GOVERNMENT AFFAIRS04/10/2026
MONTANA HEALTH SOLUTIONS, INC.BGR GOVERNMENT AFFAIRS04/10/2026
NUVATION BIO INC.BGR GOVERNMENT AFFAIRS04/10/2026
CIVALA, INC.BURRELL INTERNATIONAL GROUP LLC04/13/2026
CLEAR CHOICE THERAPEUTICSBANNER PUBLIC AFFAIRS, LLC04/13/2026
DUKE UNIVERSITY MEDICAL CENTERSIDLEY AUSTIN LLP04/13/2026
I AM BOUNDLESS INCROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)04/13/2026
INFLECTION MEDICINEIPOLICY SOLUTIONS04/13/2026
THE CIGNA GROUPRED+BLUE STRATEGIES04/13/2026
VENTURE MEDICALTHE MCMANUS GROUP04/13/2026
COLUMBUS COMMUNITY HOSPITALMERCHANT MCINTYRE & ASSOCIATES, LLC04/14/2026
COUNCIL FOR AFFORDABLE QUALITY HEALTHCAREMANATT, PHELPS, AND PHILLIPS04/14/2026
LAKE REGIONAL HEALTH SYSTEMMERCHANT MCINTYRE & ASSOCIATES, LLC04/14/2026
MAKO MEDICAL LABORATORIES LLCCHECKMATE GOVERNMENT RELATIONS04/14/2026
MCKENZIE HEALTH SYSTEMMERCHANT MCINTYRE & ASSOCIATES, LLC04/14/2026
WAYNE HEALTHCAREMERCHANT MCINTYRE & ASSOCIATES, LLC04/14/2026
TALKIATRY MANAGEMENT SERVICESTHORN RUN PARTNERS04/15/2026
AMERICAN ASSOCIATION OF INTERNATIONAL HEALTHCARE RECRUITMENTCONSTANTINOPLE & VALLONE CONSULTING LLC04/15/2026
ATRIA HEALTHARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP)04/15/2026
CAMBER HEALTHMCDERMOTT+ LLC04/15/2026
CHILD GENETIC SCREENING ALLIANCETHE CONAFAY GROUP, LLC04/15/2026
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATESALB SOLUTIONS04/15/2026
MO STRATEGIES, INC. ON BEHALF OF GIFTHEALTHKAMRAN DARAVI CONSULTING LLC04/15/2026
OHIOHEALTH CORPORATIONCORNERSTONE GOVERNMENT AFFAIRS, INC.04/15/2026
VICTOR SIMONS, MDARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP)04/15/2026
ANN & ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGOANN & ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGO04/16/2026
AXADVOCACY GOVERNMENT RELATIONS ON BEHALF OF MAIN LINE HEALTHINTEGRUS STRATEGIES, LLC04/16/2026
BIOLABWILMER CUTLER PICKERING HALE AND DORR LLP04/16/2026
MOSAIC HEALTHMICHAEL BEST STRATEGIES LLC04/16/2026
PERRIGO COMPANY PLCCOVINGTON & BURLING LLP04/16/2026
THE POLICY INSTITUTE FOR COMMUNITY BIRTH AND MIDWIFERYMCALLISTER & QUINN, LLC04/16/2026
ACT FOR ULTRA RAREAVIVA STRATEGIES (FKA MGB CONSULTING)04/17/2026
ALLIANT HEALTH SOLUTIONSVERITAS HEALTH POLICY, LLC04/17/2026
AMERICAN PHARMACISTS ASSOCIATIONMCALLISTER & QUINN, LLC04/17/2026
APCO WORLDWIDE LLC (ON BEHALF OF HIKMA PHARMACEUTICALS USA INC.)BURRELL INTERNATIONAL GROUP LLC04/17/2026
AXADVOCACY GOVERNMENT RELATIONS ON BEHALF OF PHANTOM NEUROINTEGRUS STRATEGIES, LLC04/17/2026
BICYCLE THERAPEUTICSLMH STRATEGIC SOLUTIONS04/17/2026
GAURDANT HEALTHJEFFREY J. KIMBELL & ASSOCIATES, INC.04/17/2026
GLENMARK PHARMACEUTICALSBOSE PUBLIC AFFAIRS GROUP04/17/2026
KOA BIO, LLCMCALLISTER & QUINN, LLC04/17/2026
MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)LMH STRATEGIC SOLUTIONS04/17/2026
MINIMED GROUP, INC.MINIMED GROUP, INC.04/17/2026
NATIONAL MPS SOCIETYFULCRUM PUBLIC AFFAIRS LLC04/17/2026
NEEDLESMARTMONUMENT ADVOCACY04/17/2026
FRESNO COMMUNITY HOSPITAL & MEDICAL CENTERHB STRATEGIES04/18/2026
NATIONAL ASSOCIATION OF BEHAVIORAL HEALTHCARECOZEN O'CONNOR PUBLIC STRATEGIES04/19/2026
AARPCM STRATEGIC, LLC04/20/2026
ARPA-H GOAVIVA STRATEGIES (FKA MGB CONSULTING)04/20/2026
CALIFORNIA HOSPICE AND PALLIATIVE CARE ASSOCIATIONFOLEY & LARDNER LLP04/20/2026
CHARLIE, HEALTH, INC.THE VOGEL GROUP04/20/2026
COLLEGIUM PHARMACEUTICAL INC.NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC04/20/2026
DELTA HEALTH ALLIANCEGUIDEPOSTSTRATEGIES, LLC04/20/2026
FULMER INSTRUMENTSPOTOMAC INTERNATIONAL PARTNERS, INC.04/20/2026
IMMIX BIOPHARMA INCTARPLIN, DOWNS & YOUNG, LLC04/20/2026
IPILL, INC.RK STRATEGIES, INC.04/20/2026
MANNKIND CORPORATIONJEFFREY J. KIMBELL & ASSOCIATES, INC.04/20/2026
MAYNE PHARMAG2G CONSULTING04/20/2026
NATIONAL ALLIANCE FOR DIRECT SUPPORT PROFESSIONALSGUIDE CONSULTING SERVICES, INC.04/20/2026
NEUROS MEDICAL, INC.NEUROS MEDICAL, INC.04/20/2026
RAYNER SURGICAL INC.TARPLIN, DOWNS & YOUNG, LLC04/20/2026
SOUND PHARMACEUTICALS, INC.HOLLAND & KNIGHT LLP04/20/2026
THE AMERICAN PODIATRIC MEDICAL ASSOCIATIONPOWERS PYLES SUTTER & VERVILLE, P.C.04/20/2026
TIVIC HEALTH SYSTEMSAMERICAN DEFENSE INTERNATIONAL04/20/2026
US PHARMACOPEIAKYLE HOUSE GROUP04/20/2026
VERSITI BLOOD HEALTH, INC.FOLEY & LARDNER LLP04/20/2026
COGITATIVOONMESSAGE PUBLIC STRATEGIES04/21/2026
NEW HEALTH PROGRAMS ASSOCIATIONCAPITOL PATH CONSULTING LLC FKA CULTON CONSULTING LLC04/21/2026
PHILIPS NORTH AMERICA LLCSYNDICATE STRATEGIES LLC04/21/2026
AMALGENT THERAPEUTICSPROSPERING SOLUTIONS, LLC FKA JOHN C. SNYDER III04/22/2026
COALITION OF INDEPENDENT DISPUTE RESOLUTION ENTITIES, INC. (CIDRE)KING & SPALDING LLP04/22/2026
CRESILON, INCPROSPERING SOLUTIONS, LLC FKA JOHN C. SNYDER III04/22/2026
SECURE HEALTHCARE QUALITY ALLIANCE, INC.KING & SPALDING LLP04/22/2026
U.S. RENAL CARELESTER HEALTH LAW PLLC04/22/2026
THERANICA, USA, INCDA VINCI GROUP04/24/2026
ABBOTT LABORATORIESPHRONESISDC, LLC04/27/2026
ORCA BIOADAMS AND REESE, LLP04/28/2026
AIDS UNITEDAIDS UNITED04/29/2026

Top health care ad spenders on Meta Platforms

Corporate sponsors of health care conferences and "fly-ins"

Obesity Medicine 2026 – Obesity Medicine Association (April 10–12)[10]

Gold: Amgen and Novo Nordisk

Silver: Kailera and Zealand Pharma

Bronze: Abbott Nutrition Health Institute, Genentech, and Viking Therapeutics

Discovery Dash: Guthrie Medical Group, Avocados Love One Today, Phexx, Rhythm Pharmaceuticals, and SECA

Additional: Advantage Point Behavioral, Boehringer Ingelheim, Currax Pharmaceuticals, Eli Lilly, ImpediMed, KORR Medical Technologies, Lipedema Coverage Connection, Phenomix Sciences, and Vida

AMCP 2026 – Academy of Managed Care Pharmacy (April 13–16)[11]

Agadia, Alexion, Artia Solutions, AstraZeneca, Bayer, BeOne Medicines, Bristol Myers Squibb, Cencora, Centene, CSL Behring, CVS Health, CVS Healthspire, Develop Health, Digital Health Outcomes, Epidaurus Health, Formulary Decisions, Genentech, Gilead Sciences, Johnson & Johnson, Klick Health, L’Oréal Dermatological Beauty, LEO Pharma, MedHOK, National Pharmaceutical Council, Neon Health, Nested Knowledge, Neurocrine Biosciences, Novo Nordisk, Organon, Precision AQ, Rhythm Pharmaceuticals, STATinMED, and United Therapeutics

National Community Pharmacists Association – 2026 Congressional Pharmacy Fly-In (April 15–16)[12]

American Pharmacy Cooperative, Inc., Cardinal Health, Compliant Pharmacy Cooperative, DMK Pharmacy, Good Neighbor Pharmacy, McKesson, Pharmacists Mutual, and RxPost

IMMUNOLOGY2026 – American Association of Immunologists (April 15–19)[13]

Platinum: BioLegend

Gold: Miltenyi Biotec and Waters Corporation

Silver: Abcam, Beckman Coulter, Biogen, Eli Lilly, Cytek, Stemcell Technologies, Sony, R&D Systems, and Thermo Fisher Scientific

Grants: Genentech and Merck

American Association for Cancer Research Annual Meeting 2026 (April 17–22)[14]

Cure Level ($300,000+): AstraZeneca and GSK

Progress Level ($150,000–$299,999): Daiichi Sankyo, Eli Lilly, and Victoria's Secret Global Fund for Women's Cancers

Promise Level (up to $149,999): AbbVie, American Brain Tumor Association, American Cancer Society, Amgen, Bayer, Breast Cancer Research Foundation, Canadian Institutes of Health Research, Cancer Research Institute, Chris "CJ" Johnson Foundation, Chromophobe and Oncocytic Tumor Alliance, Debbie's Dream Foundation, Doreen J. Putrah Cancer Research Foundation, Exelixis, Fondazione Pezcoller, Genmab, Gilead and Kite Oncology, Irving Weinstein Foundation, Joey's Wings, Judy Nicholson Kidney Cancer Foundation, Kidney Cancer Action Network, Kidney Cancer Association, Merck, Novartis, Parse Biosciences, Pfizer, Prostate Cancer Foundation, Regeneron, Revolution Medicines, Sanofi, Sidney Kimmel Cancer Center at Jefferson, Silken Twine Charity, St. Baldrick's Foundation, Triple Negative Breast Cancer Foundation, and VHL Alliance

National Association of Chain Drugs Stores 2026 Annual Meeting (April 18–21)[15]

Platinum: Emerson Group, Haleon, and Kenvue

Gold: Acosta, Advantage Solutions, Bayer, Camber Pharmaceuticals, Circana, Colgate-Palmolive, Force Factor, GoodRx, Mars Snacking, Pfizer, Procter & Gamble, and Unilever

Silver: 3M, AARP, Clorox Company, Edgewell, EnlivenHealth, IQVIA, PepsiCo, and Smurfit Westrock

Bronze: Abbott, Acorn, Bausch + Lomb, Beiersdorf, Cencora, Coca-Cola, Evermark, Foundation Consumer Healthcare, Hallmark, Henkel, Hercules, Kimberly-Clark, Knapp, KAO, L’Oréal, Lornamead, Lupin, McKesson, Merck, Navajo Incorporated, Nestlé, NielsenIQ, Nice Pak, Perrigo, Pharmavite, Piping Rock, Reckitt, Revlon, SCN Bestco, TruLabs, Upsher-Smith, and Yellow Wood

2026 National Lupus Advocacy Summit – Lupus Foundation of America (April 19–21)[16]

Capitol Sponsors: AstraZeneca and PhRMA

Summit Sponsors: Biogen, Cabaletta Bio, EMD Serono, Genentech, GSK, Novartis, UCB, and Viatris

Exhibit Sponsors: Aurinia Pharmaceuticals, Biotechnology Innovation Organization, Bristol Myers Squibb, Cullinan Therapeutics, Pfizer, and Zenas BioPharma

Access 2026 Leadership Summit – National Minority Quality Forum (April 27–28)[17]

Platinum Plus: Blue Cross Blue Shield Association and Centene Corporation

Platinum: Amazon, Amgen, Bristol Myers Squibb, Genentech, Gilead Sciences, Merck, Johnson & Johnson, PhRMA, Sanofi, and Vertex

Gold: American Kidney Fund, American Medical Association, Eli Lilly, and Hologic

Silver: Biogen

Bronze: Association of American Medical Colleges, Ardelyx, Blood Cancer United, Community Catalyst, DaVita, Dexcom, Keenova, Novartis, Olympus, Pfizer, Regeneron, and Xavier Ochsner College of Medicine

2026 Community Oncology Conference – Community Oncology Alliance (April 28–29)[18]

Acrotech Biopharma, Agamon Health, Amneal, Amplity, Apollo Oncology, AstraZeneca, Athena Oncology, Athenahealth, Avyxa Pharma, Candid Health, Canopy, Cencora, Colla Health, Eisai, Florida Cancer Specialists & Research Institute, Gilead Sciences | Kite Pharma, Healthier AI, House Rx, Integra Connect, Ipsen, Johnson & Johnson, Kura Oncology, McKesson | The US Oncology Network, Medscape Oncology, Navista, Nuvalent, Nuvation Bio, Organon, Partner Therapeutics, Prism TPO, Reimagine Care, RISA Labs, Tennr, Thyme Care, and Triomics

Newsletter sponsors

Sponsorships
0510

Axios (Vitals)

1Coalition to Strengthen America's Healthcare
2Healthcare Distribution Alliance
3Pharmaceutical Research and Manufacturers of America
4Biotechnology Innovation Organization

Politico – Health Care
(Pulse and Prescription Pulse)

1Coalition to Strengthen America's Healthcare
2Voices for Non-Opioid Choices

Politico – Food/Ag
(Weekly Agriculture)

1Bayer
2National Pork Producers Council

STAT News
(D.C. Diagnosis and
Morning Rounds)

1Cencora
2Cytiva
3Danaher
4Primary Care for America
5R1
6The Professional Society for Health Economics and Outcomes Research (ISPOR)
  1. Press release, “Dr. Jonathan M. Green selected as CEO of the NIH Clinical Center,” National Institutes of Health, April 21, 2026, https://www.nih.gov/news-events/news-releases/dr-jonathan-m-green-selected-ceo-nih-clinical-center.
  2. Jonathan M. Green and Stephen Rosenfeld, “Conflicts of interest in institutional review boards are a threat to ethical research,” Nature Medicine, Vol. 29, No. 8 (2023), https://www.nature.com/articles/s41591-023-02442-0.epdf.
  3. Press release, “Secretary Kennedy Appoints Casey B. Mulligan as HHS Chief Economist and Regulatory Officer,” U.S. Department of Health and Human Services, April 17, 2026, https://www.hhs.gov/press-room/hhs-appoints-casey-b-mulligan-phd-as-chief-economist-and-chief-regulatory-officer.html.
  4. Casey B. Mulligan, “Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation,” National Bureau of Economics Research, Working Paper 29574 (2021), https://www.nber.org/papers/w29574; and Joe Grogan and Casey B. Mulligan, “In Defense of Pharmacy Benefit Managers,” The Wall Street Journal, July 11, 2022, https://www.wsj.com/opinion/in-defense-of-pharmacy-benefit-managers-drugs-rebates-patient-costs-premiums-transparency-innovation-regulation-ftc-11657571932.
  5. “Nicole B. Saphier, MD,” Memorial Sloan Kettering Cancer Center, https://www.mskcc.org/cancer-care/doctors/nicole-saphier#about-me; Alex Nitzberg, “Trump taps Nicole Saphier for surgeon general, dropping Casey Means’ nomination,” Fox News, April 30, 2026, https://www.foxnews.com/health/trump-taps-nicole-saphier-surgeon-general-dropping-casey-means-nomination; and Nicole Saphier, Make America Healthy Again: How Bad Behavior and Big Government Caused a Trillion-Dollar Crisis (New York: Broadside Books, 2020).
  6. “Weight loss drugs being ‘widely overutilized’ despite benefits, Dr. Nicole Saphier says,” Fox & Friends, Fox News, November 28, 2024, https://www.foxnews.com/video/6365293691112; and Wellness Unmasked with Dr. Nicole Saphier, “Wellness Unmasked: Peptides Explained – Benefits, Risks, GLP-1s & the Longevity Hype,” iHeartMedia, April 14, 2026, https://podcasts.apple.com/us/podcast/wellness-unmasked-peptides-explained-benefits-risks/id1812416146.
  7. Wellness Unmasked with Dr. Nicole Saphier, “Wellness Unmasked Weekly Rundown: Plant-Based Diet & Dementia Risk Explained: Brain Health, Nutrition Myths, & What to Eat,” iHeartMedia, April 9, 2026, https://podcasts.apple.com/us/podcast/wellness-unmasked-weekly-rundown-plant-based-diet-dementia/id1812416146.
  8. Liz Essley Whyte, Sabrina Siddiqui, and Jennifer Calfas, “Trump Administration Eyes Erica Schwartz to Lead CDC,” The Wall Street Journal, April 14, 2026, https://www.wsj.com/politics/policy/trump-administration-eyes-erica-schwartz-to-lead-cdc-2556ce28.
  9. Dennis J. Faix, et al., “Decreased Serologic Response in Vaccinated Military Recruits during 2011 Correspond to Genetic Drift in Concurrent Circulating Pandemic A/H1N1 Viruses,” PLOS ONE, Vol. 7, No. 10 (2012), https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0034581.
  10. "Sponsors," Obesity Medicine 2026, https://obesitymedicine2026.eventscribe.net/sponsors.asp.
  11. "Sponsors," AMCP 2026, https://amcpannual.org/sponsorship/sponsors.
  12. "Congressional Pharmacy Fly-In," National Community Pharmacists Association, https://ncpa.org/congressional-pharmacy-fly.
  13. "Sponsors," IMMUNOLOGY2026, https://immunology2026.aai.org/sponsors.
  14. "Supporters," AACR Annual Meeting 2026, https://www.aacr.org/meeting/aacr-annual-meeting-2026/supporters.
  15. "Sponsors," NACDS Annual Meeting 2026, https://annual.nacds.org/sponsors.
  16. "National Lupus Advocacy Summit," Lupus Foundation of America, https://www.lupus.org/advocate/national-lupus-advocacy-summit.
  17. "Full Agenda," NMQF Leadership Summit 2026, https://summit.nmqf.org/access2026agenda.
  18. "Community Oncology Conference," 2026 Community Oncology Conference, https://coaconference.com.

About Baron

Baron has guided clients for nearly two decades through the most challenging political terrain. Applying a methodology focused on mastering the strategic competition of interests, Baron advises some of the nation's most prominent organizations, including members of the Fortune 10, several of America's largest privately held businesses, and the U.S. Department of Defense. Baron's health care sector clients have included insurers and pharmacy benefit managers, integrated health systems, and medical device firms.


© 2026 Baron Public Affairs, LLC. All Rights Reserved. No part of these materials may be reproduced or transmitted in any form or by any means, electronic or mechanical, including but not limited to photocopy, recording, or any other information storage or retrieval system known now or in the future, without the express written permission of Baron Public Affairs, LLC. These materials do not constitute advice on any particular investment or commercial issue or matter. No part of this work constitutes investment or legal advice and is not to be relied upon as such. The unauthorized reproduction or distribution of this copyrighted work is illegal and may result in civil or criminal penalties under the U.S. Copyright Act and applicable copyright law.